Skip to main content

Equibles does not estimate personal net worth.

Get an email with a short summary when Arcutis Biotherapeutics, Inc. publishes a filing, an earnings call transcript or a press release.

Get ARQT alerts

About L. Todd Edwards

Arcutis Biotherapeutics, Inc. reported in an 8-K filed September 27, 2023 that L. Todd Edwards was appointed Chief Commercial Officer, effective September 27, 2023. The proxy statement of Arcutis Biotherapeutics, Inc. reports total compensation of $3,030,337 for L. Todd Edwards in fiscal 2025, including a base salary of $535,000. Disclosed compensation is on record for 3 fiscal years. Arcutis Biotherapeutics, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Arcutis Biotherapeutics, Inc. includes Todd Franklin Watanabe (CEO and Board Member), Latha Vairavan (CFO), Masaru Matsuda (General Counsel) and 7 others.

“On September 27, 2023, Arcutis Biotherapeutics, Inc. (the "Company" or "Arcutis") announced the appointment of L. Todd Edwards as the Company's Chief Commercial Officer, effective as of September 27, 2023.”
Arcutis Biotherapeutics, Inc. Form 8-K, filed September 27, 2023 · Read the filing

Affiliation history

Company network

Leadership on record at Arcutis Biotherapeutics, Inc.

Executive compensation

Compensation components disclosed in company proxy statements. Amounts are nominal USD; total is the company-reported figure.

Fiscal year Company Salary Total
2025 Arcutis Biotherapeutics, Inc. (ARQT) $535,000 $3,030,337
2024 Arcutis Biotherapeutics, Inc. (ARQT) $516,419 $1,965,145
2023 Arcutis Biotherapeutics, Inc. (ARQT) $131,254 $1,657,847

Recent activity